Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development
Monday, February 06, 2023Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders is pleased to announce it has entered into a supply agreement with PharmAla Biotech Holdings Inc to...
Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone
Monday, February 06, 2023Sage Therapeutics Inc and Biogen Inc announced the US Food and Drug Administration FDA has accepted the filing of a New Drug Application NDA for zuranolone in the treatment of major depressive disorder MDD and postpartum depression PPD Zuranolone is...
Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding Composition of Matter for Family 1 Psilocybin Analogs
Thursday, February 02, 2023Mindset Pharma Inc a drug discovery company developing novel optimized nextgeneration psychedelic and nonpsychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs announced today that the United States Pate...
Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer
Thursday, February 02, 2023Purple Biotech Ltd a clinicalstage company developing firstinclass effective and durable therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance today announced that it has entered into an a...
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Wednesday, February 01, 2023With the increasing drug development for novel therapeutics a growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners to help meet the demand for complex fill and finish solutions And while the stages of ear...
Pharmapack Europe Awards Winners 2023
Wednesday, February 01, 2023Pharmapack Europe PharmapackEU announces the winners of the prestigious Pharmapack Awards spanning five categories across two dedicated awards The Health Product Awards are open to the entire pharma industry and include two categories for ecodesign...
Aptamer Group partner with BaseCure Therapeutics to develop new targeted gene therapies
Tuesday, January 31, 2023Aptamer Group plc the developer of novel Optimer binders to enable innovation in the life sciences industry today announces a new partnership with BaseCure Therapeutics for the development of Optimertargeted gene therapies The ability to precisely ta...
Origin Enters into Binding Letter of Intent with Safe Supply Streaming Co., a Pharmaceutical and Narcotics Investment Company with a First Mover Advantage in the Safe Supply Narcotics Sector
Tuesday, January 31, 2023Origin Therapeutics Holdings Inc announces that it has signed a binding Letter of Intent dated January the LOI with Safe Supply Streaming Co Ltd pursuant to which the Company will acquire all of the issued and outstanding securities in the capital...
Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev®
Monday, January 30, 2023Xeris Biopharma Holdings Inc a growthoriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies today announced that the Food and Drug Administration FDA g...
ScPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update
Monday, January 30, 2023ScPharmaceuticals Inc a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies advance patient care and reduce healthcare costs today announced that the company is targeting February...
